F
FLGT
Fulgent Genetics
21.74
+0.92+4.42%After Hours: 21.74 0.00 0.00%19:30 10/09 EDT
OPEN/PREV CLOSE20.82/20.82
TODAY RANGE20.82-21.79
VOL253.94K
MARKET CAP598.18M
52 WEEK RANGE13.46-31.04
AVG VOL (3M)301.71K
% TURNOVER0.78%
TURNOVER--
P/E (TTM)-7.6844
% RANGE4.66%
EPS(TTM)-2.8291
P/E(FORWARD)-7.7367
P/B0.5972
BVPS36.40
DIVIDEND--
P/S2.094
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP372.39M
SHARES OUTSTANDING27.52M
NEXT EARNINGS11/05-11/09
FREE FLOAT17.13M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
NASDAQ·09/22 17:16
PRPO vs. FLGT: Which Cancer Diagnostics Stock Has More Upside Now?
TipRanks·09/04 02:05
Top Fulgent Genetics Executives Quietly Reshuffle Their Holdings
TipRanks·08/29 02:06
Top Fulgent Genetics Executives Quietly Cash Out in Latest Insider Stock Moves
Dow Jones·08/04 14:45
Fulgent Genetics Is Maintained at Neutral by Piper Sandler
Benzinga·08/04 14:35
Piper Sandler Maintains Neutral on Fulgent Genetics, Raises Price Target to $19
TipRanks·08/04 13:26
Piper Sandler Reaffirms Their Hold Rating on Fulgent Genetics (FLGT)
TipRanks·08/04 10:57
Fulgent Genetics price target raised to $19 from $15 at Piper Sandler
NASDAQ·07/31 20:22
Noteworthy Friday Option Activity: OSG, FLGT, LQDA
TipRanks·07/31 12:25
Piper Sandler Reaffirms Their Hold Rating on Fulgent Genetics (FLGT)
Benzinga·07/31 12:03
Apple, Stryker, Coinbase And Other Big Stocks Moving Lower In Friday’s Pre-Market Session
TipRanks·07/30 21:07
Fulgent Genetics Updates Outlook After Q2 2026 Results
Benzinga·07/30 21:05
12 Health Care Stocks Moving In Thursday's After-Market Session
TipRanks·07/30 20:32
Fulgent Genetics reports Q2 adjusted EPS (58c), two estimates (44c)
TipRanks·07/30 20:32
Fulgent Genetics cuts FY26 adjusted EPS view to ($2.35)-($2.22) from ($1.59)
Seeking Alpha·07/30 20:22
Fulgent Genetics Non-GAAP EPS of -$0.58 misses by $0.12, revenue of $85.4M misses by $8.6M